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We analyzed RNA splice site usage in three HIV-1 subtype B primary isolates through 
RT-PCR amplification of spliced RNAs using a fluorescently labeled primer, with 
computerized size determination and quantitation of PCR products, which were also 
identified by clone sequencing. In one isolate, P2149-3, unusual and unreported spliced 
transcripts were detected. This isolate preferentially used for rev RNA generation a 3’ 
splice site (3’ss) located 5 nucleotides upstream of A4a, previously only identified in a 
T cell-line adapted virus and in a group O isolate, and designated A4d. P2149-3 also 
used an unreported 3’ss for rev RNA generation, designated A4h, located 20 
nucleotides upstream of 3’ss A4c. Additionally, unusual nef RNAs using 3’ss A5a and 
A7a and with exon composition 1.3.7 were identified. The identification of several 
unusual and unreported spliced transcripts in a HIV-1 primary isolate suggests a greater 





 HIV-1 RNAs are transcribed from a single promoter at the 5’ long terminal repeat and 
their relative expression is regulated through the alternative usage of splice sites. 
According to splicing patterns, HIV-1 transcripts can be assigned to three major 
categories
1,2
 (Fig. 1): 1) Unspliced RNA, coding for Gag-Pol and Pol polyproteins; 2) 
Doubly spliced (DS) transcripts, generated by excision of introns overlapping Gag-Pol 
and Vpu-Env open reading frames, coding for Tat, Rev, Nef, and Vpr proteins; and 3) 
Singly spliced (SS) transcripts, generated by excision of the Gag-Pol intron, coding for 
Env, Vpu, Vif, Vpr, and a truncated Tat protein. A fourth class of short spliced RNAs, 
using 3’ splice sites (3’ss) near the HIV-1 genome’s 3’ end, has been identified in two 
isolates in vitro
3,4
 and in a minority of viruses in vivo
5
; most of these transcripts are 
predicted to code for a 34 amino acid peptide in the C-terminus of Nef
5
, but their 
function still remains to be defined. The complexity of HIV-1 splicing is further 
increased by two additional factors: 1) the usage of redundant 3’ss for generation of rev 
RNAs, of which seven have been reported, A4a, A4b, and A4c in subtype B viruses
1,2
, 
A4f, A4g, and A4c in subtype C viruses
6
, A4d in the subtype B isolate SF2 and in the 
group O virus ANT70C, and A4e in ANT70C
7
; and 2) the optional incorporation of 
small noncoding exons in the leader sequence: exons 2 or 3 or both in tat, rev, nef, and 
env RNAs and exon 2 in vpr RNAs.  
Most studies on HIV-1 splicing have been done using T-cell line adapted viruses 
or cloned subgenomic fragments derived from them. Here we analyze splice site usage 
in three primary HIV-1 subtype B isolates, P2149-3, X2102, and X2210
8.9
, in an in vitro  
acute infection assay of peripheral blood mononuclear cells (PBMCs)
6
. PBMCs 
prestimulated with phytohemagglutinin and interleukin-2 were exposed to virus at a 
multiplicity of infection of 0.1 infectious particles per cell for 2 h. AZT at 10 µM was 
added at 8 h postinfection to avoid subsequent rounds of infection. Cells were collected 
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on days 1 through 4 and total RNA was extracted. HIV-1 splicing patterns were 
analyzed through RT-PCR followed by nested PCR, using primers recognizing 
sequences in the outermost exons common to either all DS or all SS HIV-1 RNAs. 
Reagents and PCR conditions were as described
6
, with the forward primer in the nested 
PCR 5’-labeled with VIC fluorophore, which allowed analysis through electrophoresis 
in an automated sequencer using GeneMapper software program (Applied Biosystems, 
Carlsbad, CA), which can accurately determine sizes of PCR products by running size 
standards labeled with a fluorophore emiting light at a different wavelength in the same 
capillary and quantify them by measuring peak areas.  
The GeneMapper analyses revealed that in two isolates peak sizes were 
consistent with common splice site usage reported for subtype B viruses (results not 
shown). However, in one isolate, P2149-3, several peaks with unexpected sizes were 
detected (Fig. 2). Four of the peaks derived from DS RNAs corresponded to PCR 
products with calculated sizes 303, 352, 377, and 426 nucleotides (nt), which are 4 or 5 
nt longer than expected for previously described rev RNAs using 3’ss A4a 1.4a.7, 
1.2.4a.7, 1.3.4a.7, and 1.2.3.4a.7, respectively, which were also detected, but with 
weaker signals than those of the unexpected products. Additional peaks, with sizes 281, 
336, 386, and 410 nt, which do not correspond to known HIV-1 transcripts, were also 
detected (Fig. 2). To identify the transcripts corresponding to the unexpected peaks, 
PCR products of DS RNAs from day 2 postinfection were cloned and sequenced. Of the 
40 sequenced clones (Table 1), 28 were predicted to code for Nef, nine for Rev, two for 
Tat, and one for Vpr. Among the nine rev RNA-derived clones, eight contained unusual 
or unreported splice junctions (Fig. 3, Table 1). Five of these used a 3’ss located 5 nt 
upstream of A4a. This 3’ss has been reported to be used in a ~0.3 kb cloned fragment of 





. The exon composition of the P2149-3 clones using A4d was 1.4d.7 in 
four and 1.3.4d.7 in one. Three other rev clones of P2149-3 derive from a transcript 
using a previously unreported 3’ss located 20 nt upstream of A4c, which was designated 
A4h, with exon composition 1.4h.7 (Fig. 3). Among the 28 nef clones, two used unusual 
3’ss. One spliced from 5’ splice site D1 to 3’ss A5a, located 4 nt downstream of A5 (the 





 isolates in vitro and by another virus in vivo
5
. Another nef RNA used 3’ss 
A7a, located 28 nt upstream of A7, previously identified only as a minor 3’ss in HXB2 
isolate
1
. A third nef transcript had the exon composition 1.3.7, which involves splicing 
from D1 to 3’ss A7,  previously only detected in a very small minority of transcripts in 
p89.6 isolate through next generation sequencing
4
.  
The detection of A4d and A4h splice site usage in P2149-3 by sequencing 
allowed to assign seven GeneMapper peaks with unexpected sizes to rev RNAs: 1.4d.7 
(303 nt), 1.2.4d.7 (352 nt), 1.3.4d.7 (377 nt), 1.2.3.4d.7 (426 nt), 1.4h.7 (336 nt), 
1.2.4h.7 (386 nt), and 1.3.4h.7 (410 nt). The remaining peak, of 281 nt, corresponds to 
nef 1.3.7 transcript. The analysis of PCR products derived from SS RNAs of P2149-3 
also revealed peaks with sizes predicted for env RNAs using A4d and A4h (results not 
shown). 
 The relative usage of the different 3’ss by rev RNAs in P2149-3 was quantified 
by measuring the areas under the fluorescent peaks (Table 2). A4d was used 
preferentially at all time points (mean 62.3% in the four days of the assay), followed by 
A4a (18.6%), A4h (13%), and A4b (6.1%). 
 We analyzed sequence features in the genome of P2149-3 that could explaing its 
unusual usage of splice sites for rev RNA generation. The usual elements of the 
metazoan 3’ss include an AG at the 3’ end of the intron, a branch point site (BPS), 
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usually 18-40 nt upstream of the AG, with the loosely conserved mammalian consensus 
sequence YNYURAY (the underline denotes the branch point), and a polypyrimidine 
tract (PPT) downstream of the BPS. P2149-3 has the AG dinucleotide at the intron end 
adjacent to A4d and an upstream PPT with 9 pyrymidines interspersed with 2 purines 
(Fig. 4), which coincides with the PPT used by NL4-3 isolate for splicing at A4a and 
A4b. Two BPS have been identified in NL4-3 for splicing at these two sites
11
, one of 
which is also used by SF2 isolate
7
. The sequences at these two BPS in P2149-3 are 
identical to those of NL4-3, and therefore they could also potentially be used for 
splicing at A4d, which is located 22 and 16 nt, respectively, downstream of these BPS. 
The relatively infrequent usage of A4a and A4b in P2149-3 may be explained by the 
linear scanning mechanism model for 3’ss recognition
12
, by which the nt after the first 
AG downstream of the BPS (which in P2149-3 is adjacent to A4d) is preferentially 
selected as 3’ss. With regard to A4h, P2149-3 has an AG at the intron end adjacent to 
this splice site, and upstream of it there is a pyrymidine-rich segment with 7 
pyrymidines and 3 interspersed purines. Just upstream of this segment, there is a 
sequence (UACAAAU) whith 6 nt coincident with the consensus mammalian BPS 
sequence and 5 potential base-pairings with U2 snRNP (underlined), whose 
complementarity to the BPS correlates positively to splicing efficiency
13
. The relatively 
infrequent usage of A4h in P2149-3 may derive from the suboptimal PPT sequence, 
which is interrupted by three interspersed purines and contains not more than two 
consecutives pyrymidines. Although the strongest PPTs contain long stretches of 
consecutive pyrymidines, stretches of alternating purines and pyrymidines can function 
as PPT to promote usage of a downstream 3’ss if the tract is close to the splice site
14
. In 
the case of A4h, its usage may also be promoted by a downstream exon splice enhancer 
(GAR ESE)
15
. Most subtype B isolates previosuly used for studies on HIV-1 splicing 
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(HXB2-LAI-IIIB-BRU, NL4-3, SF2, Ba_L, BH10) have an AG one nt downstream of 
the AG of A4h, and the sequences potentially used as PPT for A4h are identical to 
P2149-3 (Fig. 4). The obvious question is why the AG in the mentioned viruses is not 
used as 3’ss but A4h is used in P2149-3. One possible reason may be that in P2149-3 
the AG at the A4c position is mutated to AC, which would lead to activation of A4h or 
a compensatory increase in its usage, in accordance with cryptic 3’ss activation or 
compensatory increases in 3’ss usage occurring when a nearby competing 3’ss is 
inactivated through mutation
11
. However, there must be additional factors, since SF2 
isolate lacks the intronic AG adjacent to A4c, which is mutated to CG, and does not use 
upstream AGs for rev RNA splicing
7
. One may be that the sequence at A4h of P2149-3 
is AAG/G, which is closer to the mammalian 3’ss consensus (YAG/G) than the 
sequences one nt downstream in SF2 and other viruses used in previous studies 
(AAG/U), and therefore it may represent a better candidate for selection as 3’ss by the 
splicing machinery. In addition, in SF2 the sequence at the putative branch point of A4h 
(UAACAAU) differs from that in P2149-3, having only 4 potential base-pairings with 
U2 snRNP (underlined), which would make it a weaker branch point than the sequence 
in P2149-3, which has 5 potential base-pairings with U2 snRNP.   
 In summary, we report for the first time in a HIV-1 primary isolate (P2149-3) 
the preferential usage for rev RNA generation of 3’ss A4d, previously detected only in a 
cloned fragment of a T cell-line adapted isolate and in a group O virus
7
. P2149-3 also 
used a previously unreported 3’ss, A4h, for rev RNA generation, and three unusual nef 
transcripts were also identified in this isolate. These results point to a greater diversity 
in splice site usage by HIV-1 RNAs than previously appreciated. The high multiplicity 
of 3’ss used for rev RNA generation, currently numbering eight with A4h, may derive 





, and from the absolute dependence of HIV-1 replication on 
Rev expression, in whose absence viral replication cannot be rescued by proteins 
secreted by nearby HIV-1-infected cells, as occurs with Tat
17
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FIGURE LEGENDS    
 
Fig. 1. Schematic depiction of RNA splicing in HIV-1 subtype B. Open reading 
frames are shown as open boxes and exons as black bars. Only exons generated by 
splicing at commonly used splice sites are shown. Exons are named as previously
1,2
. All 
spliced transcripts incorporate exon 1. Optionally, exons 2 or 3 or both can be 
incorporated into tat, rev, nef, or env transcripts, and exon 2 into vpr transcripts. 
Proteins encoded in spliced RNAs are indicated on the right of the 3’ exon.  
 
Fig. 2. GeneMapper analysis of DS RNAs expressed by P2149-3. The analysis 
corresponds to day 2 after acute infection of PBMCs. Green peaks represent PCR 
products and orange peaks represent size standards. Size of PCR product, encoded gene, 
and exon composition (named as in previous studies
1,2,5
) predicted according to PCR 
product size are shown on top or on the side of each peak. Peaks with unexpected sizes, 
according to usual splice site usage by subtype B viruses, are marked with interrogation 
signs.  
 
Fig. 3. Sequences surrounding new and unusual splice junctions identified in 
P2149-3 DS RNAs. The arrow pointing downwards signals the splice junction. 5’ and 
3’ splice sites involved in splicing, named as in previous studies
1,2,5,7
 and in this study 
(see main text), are signaled, with nucleotide positions in the HXB2 genome in 
parentheses. Nearby splice sites are also indicated. Splice junctions shown are, from top 




Fig. 4. Intronic and exonic sequences surrounding rev RNA splice sites in P2149-3. 
Sequences are aligned with those of NL4-3 and SF2 isolates. AG dinucleotides in the 
intron ends adjacent to 3’ss are in bold type. Polypyrimidine tracts potentially used for 
splicing at A4d and A4h in P2149-3 are boxed. In NL4-3 and SF2 sequences, branch 
sites previously identified for rev RNA splicing
7,11
 are within ellipses. Nucleotides in 
P2149-3 potentially used as branch points for splicing at A4d and A4h (see main text) 
are indicated with arrows and those potentially base-pairing with U2 snRNP at these 
sites are underlined. 
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